Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Assets Average (2016 - 2025)

China Pharma Holdings' Assets Average history spans 15 years, with the latest figure at $23.4 million for Q4 2025.

  • For Q4 2025, Assets Average rose 65.08% year-over-year to $23.4 million; the TTM value through Dec 2025 reached $23.4 million, up 65.08%, while the annual FY2025 figure was $22.9 million, 46.34% up from the prior year.
  • Assets Average reached $23.4 million in Q4 2025 per CPHI's latest filing, up from $14.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $23.4 million in Q4 2025 to a low of $13.9 million in Q3 2024.
  • Average Assets Average over 5 years is $17.4 million, with a median of $16.8 million recorded in 2022.
  • Peak YoY movement for Assets Average: fell 19.57% in 2023, then soared 65.08% in 2025.
  • A 5-year view of Assets Average shows it stood at $20.4 million in 2021, then fell by 16.76% to $17.0 million in 2022, then fell by 6.37% to $15.9 million in 2023, then dropped by 10.9% to $14.2 million in 2024, then skyrocketed by 65.08% to $23.4 million in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Assets Average are $23.4 million (Q4 2025), $14.8 million (Q3 2025), and $14.0 million (Q2 2025).